Literature DB >> 32776307

LINC00665/miR-9-5p/ATF1 is a novel axis involved in the progression of colorectal cancer.

Xuhong Zhao1, Wenhao Weng1, Yin Long1, Weijie Pan1, Zhi Li2, Fenyong Sun3.   

Abstract

Long noncoding RNAs (lncRNAs) are abnormally expressed in many malignant tumors and involved in regulating the malignant phenotypes of cancer cells. However, the role of LINC00665 in colorectal cancer (CRC) and its regulatory mechanism remain unclear. In this study, real-time polymerase chain reaction (RT-PCR) was used to detect the expressions of LINC00665, miR-9-5p and activating transcription factor 1 (ATF1) mRNA in CRC tissues. The expression of ATF1 in CRC tissues was also detected by immunohistochemistry and Western blot. CCK-8 and colony formation assays were employed to detect cell proliferation. Cell cycle and apoptosis were detected by flow cytometry analysis. Scratch healing assay and Transwell test were exploited to detect cell migration and invasion. The targeting relationships between LINC00665 and miR-9-5p, and miR-9-5p and ATF1 were validated by dual luciferase reporter assay. We found that LINC00665 was significantly overexpressed in CRC tissues, and it was also negatively correlated with the expression of miR-9-5p and positively associated with the expression of ATF1. Besides, LINC00665 promoted the proliferation, migration and invasion of CRC cells, and inhibited cell apoptosis by sponging miR-9-5p. ATF1 was proved to be the downstream target of miR-9-5p and was indirectly regulated by LINC00665. Collectively, it is concluded that LINC00665 contributes to the progression of CRC by regulating miR-9-5p/ATF1 axis.

Entities:  

Keywords:  ATF1; CRC; LINC00665; miR-9-5p

Mesh:

Substances:

Year:  2020        PMID: 32776307     DOI: 10.1007/s13577-020-00393-z

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  40 in total

1.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

Review 2.  LncRNAs with miRNAs in regulation of gastric, liver, and colorectal cancers: updates in recent years.

Authors:  Chit Tam; Jack Ho Wong; Stephen Kwok Wing Tsui; Tao Zuo; Ting Fung Chan; Tzi Bun Ng
Journal:  Appl Microbiol Biotechnol       Date:  2019-05-06       Impact factor: 4.813

3.  Long noncoding RNA HCP5 contributes to epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation and interacting with miR-139-5p.

Authors:  Cheng Yang; Junjun Sun; Weifeng Liu; Yanhui Yang; Zhijie Chu; Tianbao Yang; Yang Gui; Du Wang
Journal:  Am J Transl Res       Date:  2019-02-15       Impact factor: 4.060

Review 4.  CASC2: An emerging tumour-suppressing long noncoding RNA in human cancers and melanoma.

Authors:  Xin Yu; Heyi Zheng; Gary Tse; Lin Zhang; William Ka Kei Wu
Journal:  Cell Prolif       Date:  2018-08-09       Impact factor: 6.831

Review 5.  A Review on Theragnostic Applications of Micrornas and Long Non- Coding RNAs in Colorectal Cancer.

Authors:  Ganesan Jothimani; Sushmitha Sriramulu; Yashna Chabria; Xiao-Feng Sun; Antara Banerjee; Surajit Pathak
Journal:  Curr Top Med Chem       Date:  2018       Impact factor: 3.295

6.  Reversing tumor stemness via orally targeted nanoparticles achieves efficient colon cancer treatment.

Authors:  Jiaqi Xu; Yinlong Zhang; Junchao Xu; Meifang Wang; Guangna Liu; Jing Wang; Xiao Zhao; Yingqiu Qi; Jian Shi; Keman Cheng; Yao Li; Sheng Qi; Guangjun Nie
Journal:  Biomaterials       Date:  2019-06-03       Impact factor: 12.479

Review 7.  Long Noncoding RNA and Cancer: A New Paradigm.

Authors:  Arunoday Bhan; Milad Soleimani; Subhrangsu S Mandal
Journal:  Cancer Res       Date:  2017-07-12       Impact factor: 12.701

8.  Long noncoding RNA SBF2-AS1 promotes colorectal cancer proliferation and invasion by inhibiting miR-619-5p activity and facilitating HDAC3 expression.

Authors:  Gang Chen; Yue Gu; Peng Han; Zhong Li; Jin-Lu Zhao; Mei-Zhuo Gao
Journal:  J Cell Physiol       Date:  2019-03-25       Impact factor: 6.384

Review 9.  Combination of CTLA-4 and PD-1 blockers for treatment of cancer.

Authors:  Anand Rotte
Journal:  J Exp Clin Cancer Res       Date:  2019-06-13

Review 10.  HOXA11 antisense long noncoding RNA (HOXA11-AS): A promising lncRNA in human cancers.

Authors:  Cheng-Wei Lu; Dan-Dan Zhou; Tian Xie; Ji-Long Hao; Om Prakash Pant; Cheng-Bo Lu; Xiu-Fen Liu
Journal:  Cancer Med       Date:  2018-07-10       Impact factor: 4.452

View more
  10 in total

Review 1.  The Biological and Molecular Function of LINC00665 in Human Cancers.

Authors:  Cheng Zhang; Shu-Ning Xu; Ke Li; Jing-Hong Chen; Qun Li; Ying Liu
Journal:  Front Oncol       Date:  2022-05-19       Impact factor: 5.738

Review 2.  LINC00665: An Emerging Biomarker for Cancer Diagnostics and Therapeutics.

Authors:  Chenming Zhong; Zijun Xie; Jinze Shen; Yunhua Jia; Shiwei Duan
Journal:  Cells       Date:  2022-05-04       Impact factor: 7.666

Review 3.  Emerging roles of activating transcription factor (ATF) family members in tumourigenesis and immunity: Implications in cancer immunotherapy.

Authors:  Meilin Chen; Yijun Liu; Yuqin Yang; Yanbing Qiu; Zhicheng Wang; Xiaoxu Li; Wenling Zhang
Journal:  Genes Dis       Date:  2021-06-03

4.  Identification and Verification of Necroptosis-Related Gene Signature and Associated Regulatory Axis in Breast Cancer.

Authors:  Ting Hu; Xiangwang Zhao; Yanxia Zhao; Jing Cheng; Jie Xiong; Chong Lu
Journal:  Front Genet       Date:  2022-02-16       Impact factor: 4.599

Review 5.  The Emerging Roles of LINC00665 in Human Cancers.

Authors:  Jing Zhu; Yirao Zhang; Xuyu Chen; Yibo Bian; Juan Li; Keming Wang
Journal:  Front Cell Dev Biol       Date:  2022-03-09

6.  Silencing LINC00665 inhibits cutaneous melanoma in vitro progression and induces apoptosis via the miR-339-3p/TUBB.

Authors:  Yi Liu; Shanshan Ma; Qichao Ma; Haigang Zhu
Journal:  J Clin Lab Anal       Date:  2022-08-05       Impact factor: 3.124

7.  The Long Noncoding RNA LINC00665 Facilitates c-Myc Transcriptional Activity via the miR-195-5p MYCBP Axis to Promote Progression of Lung Adenocarcinoma.

Authors:  Anpeng Wang; Te Zhang; Wei Wei; Hui Wang; Zeyu Zhang; Wenming Yang; Wenjie Xia; Qixing Mao; Lin Xu; Feng Jiang; Gaochao Dong
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

8.  Autophagy-related long non-coding RNA signature for ovarian cancer.

Authors:  Chan Meng; Jie-Qiong Zhou; Yong-Sheng Liao
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

9.  Up-Regulation of LINC00665 Facilitates the Malignant Progression of Prostate Cancer by Epigenetically Silencing KLF2 Through EZH2 and LSD1.

Authors:  Peng Xue; Miao Yan; Kunpeng Wang; Jinbao Gu; Bing Zhong; Chuanquan Tu
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

10.  LINC00665 up-regulates SIN3A expression to modulate the progression of colorectal cancer via sponging miR-138-5p.

Authors:  Shoushan Nan; Shuangxia Zhang; Rong Jin; Juelei Wang
Journal:  Cancer Cell Int       Date:  2022-01-31       Impact factor: 5.722

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.